昼颜

大连汇聚亚太声音 全球目光聚焦APEC“中国年”_我的网站

A |     Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。

B |     中新社大连8月26日电 题：大连汇聚亚太声音 全球目光聚焦APEC“中国年”          　　中新社记者 周昕          　　8月17日至28日，2026年亚太经合组织(APEC)第三次高官会及相关会议在辽宁省大连市举行。中方此前介绍，此次会议是出席人员规模最大、活动场次最多的一次高官会。亚太目光聚焦滨城，2300余名代表在此推动APEC框架下各领域、各机制达成更多合作成果，为11月APEC第三十三次领导人非正式会议做好准备。         　　今年11月18日至19日，APEC第三十三次领导人非正式会议将在深圳举行。

C | 这是中国第三次，也是时隔12年再次担任APEC东道主。                        　　纵观全年，从中方在广州、上海和大连举行高官会，到在多地举办的部长级会议等，各领域合作扎实推进，汇聚了一系列收获。         　　南开大学APEC研究中心主任刘晨阳介绍，APEC高官会对上承接领导人会议与部长级会议部署，对下联动各专项工作组落地落实，是全年合作成果成型的关键环节。

D | 大连第三次高官会形成的共识与研讨，将为研判重点成果提供参考方向，亦是观察APEC进程的关键时间节点。         　　刘晨阳进一步指出，大连辐射东北亚，是中国面向亚太地区开放的重要窗口。依托老工业基地产业基础，大连可充分展示传统产业与人工智能等新赛道融合的转型成果，为亚太产业创新合作提供实践参照。         　　中国社会科学院亚太与全球战略研究院研究员许利平认为，三座举办高官会的城市分别依托粤港澳大湾区、长三角地区、东北老工业基地优势，彰显了中国全方位深化亚太合作的姿态。         　　当前，地缘政治冲突、贸易保护主义等挑战交织叠加，世界经济复苏持续承压。         　　“APEC作为亚太经济合作的主渠道，其发展正是依托亚太经济在全球经济体系中的重要地位。”刘晨阳说，亚太区域合作乃至全球多边合作面临不进则退的局面，需要有效的平台或组织采取开放合作的务实举措，这正是当前APEC应当承担的功能。         　　许利平指出，APEC作为对冲逆全球化、弥补全球治理赤字的重要平台，可为各经济体搭建优势互补、互利共赢的沟通桥梁。         　　今年恰逢中国加入APEC35周年，中国将“建设亚太共同体，促进共同繁荣”确定为2026年办会主题，并提出“开放、创新、合作”三大优先领域。

E |          　　刘晨阳表示，从亚太命运共同体理念，到北京APEC“共建面向未来的亚太伙伴关系”，再到近年来四大全球倡议的提出，中方关于全球发展和治理的理念正不断融入亚太合作进程。         　　受访专家表示，APEC“中国年”系列活动将为区域经济一体化注入新动能，也为全球经济稳定复苏贡献亚太力量。

F | (完) 【编辑:蔡星雨】。

Current article:http://fsx.bomanglangsugangunxileba.cyou/dp5a0/tw3.html

Published on:00:39:06